TheHerdLocker.com Skip to content…
  • Recent
  • Popular
The most popular thoughts. Popular rankings for #oncology show you the articles which have had the most shares over the past 7 days, 30 days or the past 6-7 months.

We show you the original tweet, and the 'share' number is the number of times that the content was linked to by other twitter users: as retweets, duplicate posts, shortened URLs and so on.

Remember to check out the recent reports, showing the latest filtered tweets as fast as we can process them.

7 days 30 days 6 months+

Busy? Get Free Weekly Reports

    Previous1..3456789..16Next
First Shared by Shares URL Content Date
@CancerWallonia 0 https://www.onclive.com/web-exclusives/rucaparib-shows-encouraging-responses-in-brca-mcrpc #Rucaparib Shows Encouraging Responses in #BRCA+ #mCRPC https://shar.es/aaVHuV #oncology 12-Jan-19 12:39 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/treatment-breakthroughs-advance-care-across-heterogeneous-nsclc-population Treatment #Breakthroughs Advance Care Across Heterogeneous #NSCLC Population https://shar.es/aaVHcb #oncology 12-Jan-19 12:39 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/assessing-risk-stratification-across-pivotal-prostate-cancer-trials Assessing #Risk #Stratification Across Pivotal #Prostate #Cancer #Trials https://shar.es/aaVHGn #oncology 12-Jan-19 12:40 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/ugn101-shows-encouraging-cr-rates-in-urothelial-cancer #UGN-101 Shows Encouraging CR Rates in #Urothelial #Cancer https://shar.es/aaVH6O #oncology 12-Jan-19 12:41 Open Tweet
@CancerWallonia 0 https://www.onclive.com/publications/oncology-live/2019/vol-20-no-1/checkpoint-inhibitors-herald-new-era-in-urothelial-cancer #Checkpoint #Inhibitors Herald New Era in #Urothelial #Cancer https://shar.es/aaVHhS #oncology 12-Jan-19 12:41 Open Tweet
@CancerWallonia 0 https://www.onclive.com/publications/oncology-fellows/2018/december-2018/prostate-cancer-mortality-progress-stalls-prompting-questions-about-psa-policies #Prostate #Cancer Mortality Progress Stalls, Prompting Questions About #PSA Policies https://shar.es/aaVHC2 #oncology 12-Jan-19 12:42 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/targeted-liquid-biopsy-could-be-potential-early-screening-tool-for-endometrial-cancer Targeted Liquid Biopsy Could Be Potential Early Screening Tool for #Endometrial #Cancer https://shar.es/aaVHYJ #oncology 12-Jan-19 12:42 Open Tweet
@CancerWallonia 0 https://www.onclive.com/publications/oncology-live/2019/vol-20-no-1/cdk46-inhibitors-explored-in-adjuvant-breast-cancer-setting #CDK4/6 #Inhibitors Explored in Adjuvant #Breast #Cancer Setting https://shar.es/aaVHea #oncology 12-Jan-19 12:43 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/nivolumab-improves-os-in-advanced-or-recurrent-esophageal-cancer #Nivolumab Improves #OS in Advanced or Recurrent #Esophageal #Cancer https://shar.es/aaVHd3 #oncology 12-Jan-19 12:43 Open Tweet
@CancerWallonia 0 https://www.onclive.com/publications/special-issues/2019/inhibition-of-the-bcl-2-pathway-in-hematologic-malignancies/bcl2-mechanisms-and--prevalence #BCL-2: Mechanisms and Prevalence https://shar.es/aaVHij #oncology 12-Jan-19 12:47 Open Tweet
  • @CancerWallonia
    12-Jan-19 12:39 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/rucaparib-shows-encouraging-responses-in-brca-mcrpc
    • #Rucaparib Shows Encouraging Responses in #BRCA+ #mCRPC https://shar.es/aaVHuV #oncology
  • @CancerWallonia
    12-Jan-19 12:39 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/treatment-breakthroughs-advance-care-across-heterogeneous-nsclc-population
    • Treatment #Breakthroughs Advance Care Across Heterogeneous #NSCLC Population https://shar.es/aaVHcb #oncology
  • @CancerWallonia
    12-Jan-19 12:40 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/assessing-risk-stratification-across-pivotal-prostate-cancer-trials
    • Assessing #Risk #Stratification Across Pivotal #Prostate #Cancer #Trials https://shar.es/aaVHGn #oncology
  • @CancerWallonia
    12-Jan-19 12:41 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/ugn101-shows-encouraging-cr-rates-in-urothelial-cancer
    • #UGN-101 Shows Encouraging CR Rates in #Urothelial #Cancer https://shar.es/aaVH6O #oncology
  • @CancerWallonia
    12-Jan-19 12:41 Open Tweet
    0 shares
    • https://www.onclive.com/publications/oncology-live/2019/vol-20-no-1/checkpoint-inhibitors-herald-new-era-in-urothelial-cancer
    • #Checkpoint #Inhibitors Herald New Era in #Urothelial #Cancer https://shar.es/aaVHhS #oncology
  • @CancerWallonia
    12-Jan-19 12:42 Open Tweet
    0 shares
    • https://www.onclive.com/publications/oncology-fellows/2018/december-2018/prostate-cancer-mortality-progress-stalls-prompting-questions-about-psa-policies
    • #Prostate #Cancer Mortality Progress Stalls, Prompting Questions About #PSA Policies https://shar.es/aaVHC2 #oncology
  • @CancerWallonia
    12-Jan-19 12:42 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/targeted-liquid-biopsy-could-be-potential-early-screening-tool-for-endometrial-cancer
    • Targeted Liquid Biopsy Could Be Potential Early Screening Tool for #Endometrial #Cancer https://shar.es/aaVHYJ #oncology
  • @CancerWallonia
    12-Jan-19 12:43 Open Tweet
    0 shares
    • https://www.onclive.com/publications/oncology-live/2019/vol-20-no-1/cdk46-inhibitors-explored-in-adjuvant-breast-cancer-setting
    • #CDK4/6 #Inhibitors Explored in Adjuvant #Breast #Cancer Setting https://shar.es/aaVHea #oncology
  • @CancerWallonia
    12-Jan-19 12:43 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/nivolumab-improves-os-in-advanced-or-recurrent-esophageal-cancer
    • #Nivolumab Improves #OS in Advanced or Recurrent #Esophageal #Cancer https://shar.es/aaVHd3 #oncology
  • @CancerWallonia
    12-Jan-19 12:47 Open Tweet
    0 shares
    • https://www.onclive.com/publications/special-issues/2019/inhibition-of-the-bcl-2-pathway-in-hematologic-malignancies/bcl2-mechanisms-and--prevalence
    • #BCL-2: Mechanisms and Prevalence https://shar.es/aaVHij #oncology
    Previous1..3456789..16Next
Press   About   Terms of Use   Privacy   Free Weekly Reports   

© The Herd Locker 2016-2019. Bugs, questions or suggestions? Want to track a new hashtag? Just ask.

Loading…